Vitamin D deficiency and myocardial structure and function in older men and women: The Hoorn study

Journal of Endocrinological Investigation

Volumn 33, Issue 9, 2010, Pages 612-617

  Pilz, Stefan ^a   Henry, R M A ^b,c   Snijder, M B ^b,d   Van Dam, R M ^e,f   Nijpels, G ^b,g   Stehouwer, C D A ^c   Kamp, O ^h   Tomaschitz, A ^a   Pieber, T R ^a   Dekker, J M ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f CHANNING LABORATORY   (United States)

^g Department of General Practice ^*  (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

25 hydroxyvitamin D; Cardiovascular disease; Heart failure; Myocardial dysfunction; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; SEX DIFFERENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 78650854901     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03346658     Document Type: Article

References (40)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357: 266-81.
2. Papapetrou PD, Triantafyllopoulou M, Korakovouni A. Severe vitamin D deficiency in the institutionalized elderly. J Endocrinol Invest 2008, 31: 784-7.
3. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29: 726-76.
4. Peterlik M, Cross HS. Dysfunction of the vitamin D endocrine system as common cause for malignant and other chronic diseases. Anticancer Res 2006, 26: 2581-88.
5. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008, 52: 1949-56.
6. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168: 1174-80.
7. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92: 2017-29.
8. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol, 2009, 6: 621-30.
9. Pilz S, März W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93: 3927-35.
10. Kendrick J, Targher G, Smits G, Chonchol M. 25-hydroxyvitamin D is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009, 205: 255-60.
11. Pilz S, Dobnig H, Nijpels G, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009; 71: 666-72.
12. Michos ED, Streeten EA, Ryan KA, et al. Serum 25-hydroxyvitamin D levels are not associated with subclinical vascular disease or C-reactive protein in the older order Amish. Calcif Tissue Int 2009, 84: 195-202.
13. Pilz S, Henry RM, Snijder MB, et al. 25-hydroxyvitamin D is not associated with carotid intima-media thickness in older men and women. Calcif Tissue Int 2009, 84: 423-4.
14. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 2006, 11: 25-33.
15. Alsafwah S, Laguardia SP, Nelson MD, et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008, 335: 292-7.
16. Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008, 52: 1106-12.
17. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knock-out cardiomyocyte contractility. Endocrinology 2008, 149: 558-64.
18. Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005, 288: 125-32.
19. Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 2007, 104: 16810-5. (Pubitemid 350210947)
20. Mancuso P, Rahman A, Hershey SD, Dandu L, Nibbelink KA, Simpson RU. 1,25-dihydroxyvitamin D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. J Cardiovasc Pharmacol 2008, 51: 559-64.
21. Koleganova N, Piecha G, Ritz E, Gross ML. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. Nephrol Dial Transplant 2009, 24: 778-87.
22. Maiya S, Sullivan I, Algrove J, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable cause of life-threatening infant heart failure. Heart 2008, 94: 581-4
23. Mooy JM, Grootenhuis PA, de Vries H, et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care, 1995, 18: 1270-3.
24. van Dam RM, Snijder MB, Dekker JM, et al. Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr 2007, 85: 755-61.
25. Levey AS, Coresh J, Balk E, et al. National Kideny Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139: 137-47.
26. Henry RM, Paulus WJ, Kamp O, et al. Deteriorating glucose tolerance status is associated with left ventricular dysfunction. the Hoorn Study. Neth J Med 2008, 66: 110-7.
27. Henry RM, Kamp O, Kostense PJ et al. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation. Diabetes Care 2004, 27: 522-529.
28. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiography assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57: 450-8.
29. Heesen WF, Beltman FW, Smit AJ, May JF. A simple nomogram for determination of echocardiographic left ventricular geometry. Am J Cardiol 1998, 82: 485-9.
30. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83: 754-9. (Pubitemid 44713136)
31. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008, 4: 404-12.
32. Scottili M, Cosmi L, Borgogni E, et al. Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells. Exp Cell Res 2009, 315: 264-73.
33. Celis R, Torre-Martinez G, Torre-Amione G. Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Curr Opin Cardiol 2008, 23: 254-60.
34. Green JJ, Robinson DA, Wilson GE, Simpson RU, Westfall MV. Calcitriol modulation of cardiac contractile performance via protein kinase C. J Moll Cell Cardiol 2006, 41: 350-9.
35. McGoingle RJ, Fowler MB, Timmis AB, Wston MJ, Parsons V. Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone. Nephron 1984, 36: 94-100.
36. Park CW, Oh SY, Shin SY, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyreoidism. Am J Kideny Dis 1999, 33: 73-81.
37. Lemmilä S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol 1998, 18: 404-10.
38. Kim HW, Park CW, Shin YS, et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyreoidism on hemodialysis. Nephron Clin Pract 2006, 102: 21-9.
39. Bikle DD. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008, 17: 348-52.
40. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007, 28: 2539-50.